Study of Hormone Use in Menopause Reaffirms Complex Mix of Risks and Benefits
Oct 04, 2013

The Journal of the American Medical Association recently published a comprehensive overview of the findings of the Women’s Health Initiative hormone therapy trials. It concludes “Menopausal hormone therapy has a complex pattern of risks and benefits.”

The conclusion supports our position that while hormone therapy is not a “longevity drug” for lifetime use, it remains an important and appropriate therapy for management of menopausal symptoms. At Seattle Women’s, we are dedicated to the careful and individualized assessment of risks vs. benefits for each individual. We believe this is critical to good patient care. Working together we can assess how the vast array of information about hormone therapy can be applied to your individual needs and discuss the many options that are available.

We are fortunate to be able to offer our patients currently marketed treatments for menopause symptoms, as well as the opportunities to participate in Clinical Research Trials that focus on emerging treatments. We currently have two clinical trials offering novel therapies:
A non-hormonal investigational medication for the treatment of menopausal hot flashes
A bioidentical hormone therapy, combining a bioidentical estrogen and bioidentical progesterone for the treatment of menopausal symptoms in women

For many women, vaginal dryness and painful intercourse develop after menopause. Several treatments are available, but expense, coupled with poor insurance reimbursement remains a significant barrier for treatment. We are currently enrolling a clinical trial for the treatment of vaginal dryness:
An investigational generic vaginal estrogen for the treatment of vaginal dryness and painful intercourse

Other currently enrolling studies include:
Overactive Bladder
Female orgasmic disorder
Irritable Bowel syndrome

Please visit our current studies page for a complete list: Current Studies . For more information about research studies, contact our recruitment department at 206-522-3330 x2 or email

Original article: Manson, JAMA 2013:310(13)1353-1368

 View the Article

Seattle Women’s News
Apr 26, 2013

Dr. Irene Piekarksi, our much esteemed colleague at Seattle Women’s, recently announced her retirement after 40 years of practice. She will be greatly missed by patients and staff alike. We at Seattle Women’s wish her a happy and healthy retirement. Both Dr. Kroll and Susan Vendeland, ARNP will be available to assume care for Dr. Piekarski’s patients.

At this time, Robin Kroll, MD, FACOG, NCMP, is accepting new patients. In addition to her special expertise in Menopause, Female Sexual Dysfunction and Vulvar Disorders, Dr. Kroll sees patients for annual exams and general women’s health care issues. She maintains daily office hours and additionally offers Saturday hours for your convenience.

Seattle Women’s currently has research studies that are recruiting both women and men, including our migraine, acne and overactive bladder studies. We are recruiting women only for our endometriosis, contraception gel, hot flash and other studies. Please visit our current studies page for a complete list: Current Studies . For more information about research studies, contact our recruitment department at 206-522-3330 x2 or email

 View the Article

Unique Medical Research Study Evaluating an Investigational Medication for Weight Loss
Sep 27, 2012

One of the biggest public health issues in the United States today is obesity. Affecting 93 million Americans, obesity has reached epidemic proportions. It not only increases the risk of heart disease and type 2 diabetes, but also some types of cancer, sleep apnea and potentially a variety of other conditions. Medical research suggests that losing just 5 percent of your body weight can significantly improve your health and quality of life. However, many people cannot achieve this type of weight loss with diet and exercise alone, and few safe and effective medications are currently approved by the U.S. Food and Drug Administration for the long-term management of weight loss.

Seattle Women’s recently began enrolling patients in the Light Study, a unique medical research study evaluating an investigational drug that has been shown to help people lose weight, keep it off for one year, and improve measures of health and well-being including losing inches from their waistlines, improving their cholesterol numbers, and making significant improvements in their blood sugar levels.

You may qualify for the Light Study if you are a man age 45 or older, or a woman age 50 or older, need to lose weight, and have heart disease and/or type 2 diabetes with certain heart risk factors.

Those who qualify and choose to participate in the Light Study will take part in an innovative, comprehensive weight management program called WeightMate™. Delivered through an internet-based platform by accredited health and fitness professionals, WeightMate provides a convenient, progressive nutrition and exercise program with goal setting and tracking tools.

“Obesity requires a comprehensive medical approach, and many people who are obese need medical intervention to get the help they need to achieve their healthy weight,” said Dr. Robin Kroll, an investigator in the Light Study. “However, options are currently limited, and new weight loss management approaches are needed. Those who have struggled to find success in losing weight and sustaining it may benefit from enrolling in the Light Study.”

Individuals interested in learning about the Light Study can contact Seattle Women’s at 206-522-3330 x2. If you participate in the Light Study you may also have the opportunity to receive the investigational medication. There is no guarantee that the study medication will cause you to lose weight.

 View the Article